Beleave Inc. (CSE: BE) (CSE: BE.CN) (CNSX: BE) (“Beleave” or the “Company”) is pleased to announce that since receiving its cultivation license, the growing space at its facility near Hamilton, Ontario has been prepared, and rooted starting material has been planted. The Company anticipates it will commence its first flowering cycle in the next week with this cycle, in its entirety, scheduled to last approximately eight weeks.
The Company will utilize its multi-room indoor perpetual growing methodology and has anticipated a harvest to take place approximately every seven weeks after the completion of the first. The first crop will consist of three batches of strain offerings with varying THC/CBD concentrations. In the coming weeks, two additional strain offerings will be introduced to complete an agreed upon spectrum.
The Beleave team is also working diligently, with the support of its expert consultants and advisors, to satisfy all remaining requirements for a sales license from Health Canada.
Beleave Inc. is a biotech company and Beleave’s wholly-owned subsidiary First Access Medical Inc. (“FAM”) is a licensed producer pursuant to the ACMPR. Beleave’s purpose-built facility is in Hamilton, Ontario.
This news release contains forward-looking information. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking information. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. These risks and uncertainties include, but are not limited to, the Company’s ability to satisfy the conditions associated with its cultivation license, the Company’s ability to obtain a sales license and the related timing considerations, receiving regulatory approvals in connection with its proposed expansion, the availability of further financing, consumer interest in its products, competition, regulation, operational and technological risks, and anticipated and unanticipated costs and delays. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speaks only as of the date of this news release. Actual results could differ materially from those currently anticipated due to several factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com.
Click here to connect with Beleave Inc. (CNSX:BE) to receive an Investor Presentation
ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Aurora Cannabis Inc. Investors of Important December 1 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ACB
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.
To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email firstname.lastname@example.org or email@example.com for information on the class action.
UPCOMING DEC. 1 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Aurora Cannabis Inc. – ACB
Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.
The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.
Also this week, new data showed sales of Canadian cannabis edible products may be stalling.
The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.
Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.
Portnoy Law Firm: Credit Acceptance Corporation, Aurora Cannabis, Inc., and Loop Industries, Inc. Investors Have Limited Amount of Time Before Class Action Deadline
The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.
Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .